The subgroup study showed that CEA, CA15-3, CA19-9, NSE, proGRP, and HE4 were elevated in patients with CKD having normal serum creatinine compared with those in the control group (<i>p</i> < 0.05). This evidence concerns the gene WFDC2 and chronic kidney disease.